Optovue’s AngioVue imaging system receives FDA clearance
Optovue announced FDA clearance and immediate U.S. commercial availability of the AngioVue™ Imaging System, a groundbreaking technology that provides a non-invasive way to visualize abnormal blood vessels in the retina to help physicians determine an appropriate course of treatment.
[adsense:336x280:8701650588]
The AngioVue System, with its proprietary technology, provides physicians with a non-invasive, dyeless technique for quickly visualizing the presence or absence of flow in the blood vessels.
[adsense:468x15:2204050025]
This enables the assessment of new information from the microvasculature and perfusion in ocular diseases with extraordinary detail.